14-3-3 protein zeta/delta (1433Z) was discovered as a putative prognostic marker for renal cell carcinoma (Masui et al, 2013) and for monitoring chemotherapy in breast cancer (Hodgkinson et al, 2012). This evidence concerns the gene YWHAZ and breast carcinoma.